comparemela.com

Latest Breaking News On - கல்லீரல் மாற்று அலகு - Page 1 : comparemela.com

Vadapalani s SIMS Hospitals performs successful microsurgical liver transplant, first-of-its-kind in Tamil Nadu

Vadapalani s SIMS Hospitals performs successful microsurgical liver transplant, first-of-its-kind in Tamil Nadu ANI | Updated: Apr 01, 2021 17:17 IST Chennai (Tamil Nadu) [India], April 1 (ANI/NewsVoir): SIMS Hospitals (SRM Institutes for Medical Science) Vadapalani, one of the leading multi-speciality hospitals in Chennai, performed successful Liver transplant surgery under an operating microscope, marking a significant development in the field of Liver transplant surgery in the State of Tamil Nadu. This skill-intensive Microsurgical Liver transplant evidently reduces the post-surgical complications to a larger extent and ensures better outcomes for patients. Sharing his thoughts on the successful transplant and the benefits of Microsurgical Liver Transplant Surgery, Dr S. Vivekanandan, Lead Surgeon, Liver Transplant, SIMS, said, Conventionally, liver transplants are done using magnifying glasses (also known as Surgical Loupes) to enhance

Vadapalani s SIMS Hospitals performs successful microsurgical liver transplant, first-of-its-kind in Tamil Nadu

Vadapalani s SIMS Hospitals performs successful microsurgical liver transplant, first-of-its-kind in Tamil Nadu
business-standard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from business-standard.com Daily Mail and Mail on Sunday newspapers.

Coronavirus | Covaxin gets central drugs authority panel approval for restricted use

Coronavirus | Covaxin gets central drugs authority panel approval for restricted use Updated: Updated: Bharat Biotech’s vaccine candidate approved for use in clinical trial mode. Share Article AAA A health worker administers Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, during phase- 3 trials for the vaccine candidate at the People’s Medical College in Bhopal on December 7, 2020.   | Photo Credit: PTI Bharat Biotech’s vaccine candidate approved for use in clinical trial mode. India’s first indigenously developed COVID-19 vaccine, Covaxin, has been recommended for “restricted use in emergency situation, subject to multiple regulatory conditionalties” by the Subject Expert Committee (SEC) of Central Drugs Standard Control Organisation (CDSCO), here on Saturday. The Drugs Controller General (DCGI) will take a final call on approving rollout of the vaccine in the country.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.